Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 2Suspended 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 11Genitourinary 8Endocrine 4CNS 4NET 3Lymphoid 3Thoracic 2Other solid neoplasm 2Other hematologic neoplasm 2Gynecologic 2Plasma cell 1Myeloid 1Head & Neck 1Breast 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Solid Tumor, Adult 1

Interventions

Cisplatin 81Gemcitabine 58Carboplatin 57Irinotecan 56Paclitaxel 53Pemetrexed 47Docetaxel 39Nivolumab 33Fluorouracil 30Bevacizumab 27pembrolizumab 25Cyclophosphamide 24Capecitabine 24Oxaliplatin 22Leucovorin 21Topotecan 19durvalumab 17Erlotinib Hydrochloride 17Sorafenib 16Everolimus 16Etoposide 16Bortezomib 16Ipilimumab 15Injections 15Sunitinib 14Filgrastim 14Early Intervention, Educational 14atezolizumab 13alvocidib 13Sirolimus 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Positron-Emission Tomography × Other solid neoplasm × Clear all
NCT02055586 2020-09-18

FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents

Case Comprehensive Cancer Center

Completed
10 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT02717572 2019-04-05

18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR

Washington University School of Medicine

Phase 1 Completed
19 enrolled
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡